SCHEMBL18178581

SCHEMBL18178581

CCC(=O)Oc1cccc(CC)c1COc1cc(F)c(C)cc1C

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MRGPRX4 Q96LA9 5/20 0.43
ACHE P22303 1/20 0.37
SLC22A12 Q96S37 1/20 0.37
KDM4E B2RXH2 2/20 0.36
HPGD P15428 2/20 0.36
HSD17B10 Q99714 2/20 0.36
LMNA P02545 1/20 0.36
GLA P06280 1/20 0.36
GAA P10253 1/20 0.36
MAPK1 P28482 1/20 0.36
KMT2A Q03164 1/20 0.36
ACLY P53396 1/20 0.35
ALDH1A1 P00352 1/20 0.34
NPSR1 Q6W5P4 1/20 0.34
PTGDR2 Q9Y5Y4 1/20 0.34
MAPT P10636 1/20 0.34
GUCY1B2 O75343 4/20 0.34
GUCY1A2 P33402 4/20 0.34
GUCY1A1 Q02108 4/20 0.34
GUCY1B1 Q02153 4/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18178592 0.93 MRGPRX4 (0.41) MRGPRX4ACHESLC22A12KDM4EHPGD
SCHEMBL18178545 0.93 MRGPRX4 (0.40) MRGPRX4ACHESLC22A12KDM4EHPGD
SCHEMBL18182248 0.93 MRGPRX4 (0.43) MRGPRX4ACHESLC22A12KDM4EHPGD
SCHEMBL18178594 0.93 MRGPRX4 (0.38) MRGPRX4ACHESLC22A12KDM4EHPGD
SCHEMBL18178582 0.92 MRGPRX4 (0.41) MRGPRX4ACHESLC22A12KDM4EHPGD
SCHEMBL18178578 0.91 MRGPRX4 (0.44) MRGPRX4ACHESLC22A12KDM4EHPGD
SCHEMBL18178574 0.91 MRGPRX4 (0.44) MRGPRX4ACHESLC22A12ACLYALDH1A1
SCHEMBL18178749 0.90 NPSR1 (0.41) MRGPRX4ACHESLC22A12KDM4EHPGD
SCHEMBL18178565 0.90 MRGPRX4 (0.40) MRGPRX4ACHEKDM4EHPGDHSD17B10
SCHEMBL18178572 0.90 MRGPRX4 (0.36) MRGPRX4ACHESLC22A12KDM4EHPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9573904-B2 Aromatic compound and use thereof SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2017-02-21 US disclosed
US-20160311775-A1 AROMATIC COMPOUND AND USE THEREOF SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 2016-10-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160311775-A1 AROMATIC COMPOUND AND USE THEREOF ZCCHC8, CBR3, CBX8 MRGPRX4 167/4885ACHE 460/4885SLC22A12 4500/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.